Financial Outcomes of Managed Entry Agreements for Pharmaceuticals in Italy.

ABSTRACT:

Importance

Most countries in the Organisation for Economic Co-operation and Development apply managed entry agreements (MEAs), reimbursement arrangements between manufacturers and payers, to pharmaceuticals. Few data exist regarding their ability to lower expenditures.

Objective

To analyze the financial outcomes of MEAs for pharmaceuticals from 2019 to 2021 in Italy.

Design, setting, and participants

In this observational study of MEAs and pharmaceutical spending in Italy, medications that were monitored through individually collected data and generated paybacks from manufacturers during the 2019 to 2021 study period were included in the analysis. Payback data were collected through pharmaceutical spending monitoring activities conducted by the Agenzia Italiana del Fa

SUBMITTER: Trotta F 

PROVIDER: S-EPMC10755625 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature